Periprocedural Stroke

WASHINGTON — In an exploratory analysis of the PROTECTED TAVR trial of patients undergoing transcatheter aortic valve replacement, cerebral embolic protection reduced risk for short-term stroke in patients from the U.S. but not elsewhere.

Use of the Sentinel Cerebral Protection System (Boston Scientific) to reduce risk for periprocedural stroke after TAVR.

BOSTON — In this Healio video exclusive, B. Hadley Wilson, MD, FACC, discussed late-breaking research in transcatheter aortic valve replacement, and more presented at TCT 2022.

BOSTON — In this Healio video exclusive, Dipti Itchhaporia, MD, FACC, FESC, discusses some of the highlights in late breaking science presented at TCT 2022.

BOSTON — In PROTECTED TAVR, the largest-ever randomized trial of transcatheter aortic valve replacement, cerebral embolic protection did not decrease incidence of periprocedural stroke.

In a systematic review and meta-analysis, a history of cancer was not associated with adverse short- and long-term outcomes in patients who had transcatheter aortic valve replacement.